Among 256 patients examined, 145 were diagnosed with multidrug-resistant pulmonary TB: 67 children and 78 teenagers from the focies with the multidrug-resistant TB (the main group), and 111 patients (35 children and 76 teenagers) from the focies with a chemosensitive TB (the control group). Molecular genetic testing of sputum, including the GeneXpert MTB / RIF method and the Hain Lifesciences linear probe analysis, was used to diagnose MRTB. It was found that the pulmonary TB was by 4.
View Article and Find Full Text PDF